Intra-Cellular Therapies Inc (ITCI)
85.51
-0.13
(-0.15%)
USD |
NASDAQ |
Nov 21, 16:00
85.51
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Price: 85.51 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 83.35 | 86.36 | 82.77 | 85.64 | 384196.0 |
| Nov 19, 2024 | 82.64 | 83.49 | 81.90 | 83.35 | 703926.0 |
| Nov 18, 2024 | 83.56 | 83.60 | 81.83 | 82.47 | 585319.0 |
| Nov 15, 2024 | 86.77 | 87.12 | 83.21 | 83.42 | 628182.0 |
| Nov 14, 2024 | 88.00 | 89.33 | 87.40 | 87.63 | 616356.0 |
| Nov 13, 2024 | 88.49 | 89.62 | 87.52 | 88.22 | 982148.0 |
| Nov 12, 2024 | 91.00 | 91.52 | 88.18 | 88.49 | 791570.0 |
| Nov 11, 2024 | 91.73 | 93.45 | 90.63 | 91.57 | 922131.0 |
| Nov 08, 2024 | 89.57 | 91.40 | 89.28 | 91.29 | 585634.0 |
| Nov 07, 2024 | 89.86 | 91.68 | 89.41 | 90.51 | 586500.0 |
| Nov 06, 2024 | 90.00 | 90.25 | 87.48 | 89.44 | 697819.0 |
| Nov 05, 2024 | 85.79 | 89.44 | 85.08 | 89.24 | 507400.0 |
| Nov 04, 2024 | 86.41 | 87.31 | 86.02 | 86.17 | 713064.0 |
| Nov 01, 2024 | 84.84 | 86.98 | 84.36 | 86.54 | 935219.0 |
| Oct 31, 2024 | 85.01 | 86.88 | 84.57 | 84.75 | 1.082M |
| Oct 30, 2024 | 78.89 | 88.00 | 76.76 | 85.47 | 2.525M |
| Oct 29, 2024 | 77.24 | 78.02 | 75.57 | 76.75 | 690135.0 |
| Oct 28, 2024 | 75.93 | 77.05 | 75.58 | 76.82 | 650915.0 |
| Oct 25, 2024 | 75.60 | 76.87 | 75.25 | 75.81 | 410853.0 |
| Oct 24, 2024 | 75.22 | 76.04 | 74.80 | 75.64 | 251523.0 |
| Oct 23, 2024 | 76.52 | 76.98 | 74.76 | 75.02 | 270812.0 |
| Oct 22, 2024 | 76.52 | 78.03 | 76.17 | 77.09 | 344235.0 |
| Oct 21, 2024 | 77.94 | 78.47 | 76.56 | 76.91 | 468461.0 |
| Oct 18, 2024 | 78.22 | 79.46 | 78.04 | 78.34 | 505843.0 |
| Oct 17, 2024 | 76.46 | 78.84 | 76.42 | 78.68 | 455568.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
9.22
Minimum
Nov 25 2019
91.57
Maximum
Nov 11 2024
47.20
Average
48.78
Median
Price Benchmarks
| Ionis Pharmaceuticals Inc | 33.94 |
| AbbVie Inc | 171.70 |
| NovaBay Pharmaceuticals Inc | 0.718 |
| Palatin Technologies Inc | 0.91 |
| iBio Inc | 2.45 |
Price Related Metrics
| PS Ratio | 14.05 |
| Price to Book Value | 7.919 |
| Earnings Yield | -1.02% |
| Market Cap | 9.066B |